Researching, developing, and providing accessible cancer medications to Canadians

Learn more

BeiGene News

November 18, 2024
BeiGene Canada Announces Inaugural Grant Recipients at New Brunswick’s Health Research Symposium
October 29, 2024
BeiGene Canada Proud National Sponsor of the Leukemia & Lymphoma Society of Canada’s 2024 Light The Night
May 7, 2024
Biotech Leader, BeiGene, Inaugurates Office in Toronto, Canada
Feb 7, 2024
Health Canada Approves BRUKINSA® (zanubrutinib) for the Treatment of Relapsed or Refractory Follicular Lymphoma
Jan 31, 2024
Adults living with chronic lymphocytic leukemia (CLL) in Ontario and Quebec now have access through public reimbursement to BRUKINSA® (zanubrutinib)
Oct 30, 2023
Helping Canadian Cancer Research & Innovation – BeiGene Canada’s Pioneering Fund
Aug 21, 2023
Press Conference: Peter Brenders announces the launch of the BeiGene Canada Fund for Research and Innovation
Aug 21, 2023
BeiGene Canada Invests 500K To Fund Innovative Cancer Research
May 30, 2023
Health Canada Approves BRUKINSA® (zanubrutinib) for the Treatment of Chronic Lymphocytic Leukemia (CLL), the Most Common Leukemia in Adult
Feb 6, 2023
Quebec becomes first province to cover BRUKINSA® (zanubrutinib) for the Treatment of Waldenström’s macroglobulinemia
Jan 9, 2023
BeiGene Canada Named a Great Place to Work®
April 8, 2021
BeiGene Launches BRUKINSA® (Zanubrutinib) in Canada for Patients with Waldenström’s Macroglobulinemia
Read More News

Our Purpose

Ensure that Canadian patients, caregivers, clinicians, and investigators have timely access to novel, effective and affordable oncology medications.

Learn More
BeiGeneCAN_WhatWeDo_Products2-Body

Our Products

We are advancing an innovative, high-value product portfolio for patients globally, providing best in-class medications for blood cancers and solid tumors.

Learn More
BG_Products

Putting Patients First

We offer resources to help patients and their loved ones navigate some of the complex challenges that follow the words, “You have cancer.”

Learn More
BeiGeneCAN_WhatWeDo_Main-3-Patients

Passion with Purpose

We work to benefit patients wherever they live by uniting worldwide talent and resources with our vision.

Learn More
BeiGenCAN_WhoWeAre_Main4-Join-Our-Teams

Mission Critical Partnerships

Partnering with the best minds in academia, biotech, pharma and patient advocacy.

Learn More
BeiGeneCAN_AboutUs_OurValues

Affiliations and Collaborations

Logo for BIOTECanada, featuring blue text and a design of interlocking green and blue loops above the text.
Logo for Life Sciences Ontario (LSO), featuring green and blue intertwined helix shapes and the text
Logo for Life Sciences British Columbia, featuring blue text and a stylized design of intertwined blue shapes.
Logo for the Waldenstrom's Macroglobulinemia Foundation of Canada (WMFC), featuring a blue torch with a red flame and the organization's name in blue text.
Logo for the Canadian Organization for Rare Disorders (CORD), featuring blue text and a stylized design of a person within the letter
Logo for Lymphoma Canada, featuring a purple circle with a stylized branching tree design and black text.
Logo for the Leukemia & Lymphoma Society of Canada, featuring a red droplet and grey text.
Logo for CLL LLC Canada, featuring a stylized red maple leaf with a drop in the center, symbolizing the Canadian focus and perhaps a healthcare or medical theme.
  • Logo for BIOTECanada, featuring blue text and a design of interlocking green and blue loops above the text.
  • Logo for Life Sciences Ontario (LSO), featuring green and blue intertwined helix shapes and the text
  • Logo for Life Sciences British Columbia, featuring blue text and a stylized design of intertwined blue shapes.
  • Logo for the Waldenstrom's Macroglobulinemia Foundation of Canada (WMFC), featuring a blue torch with a red flame and the organization's name in blue text.
  • Logo for the Canadian Organization for Rare Disorders (CORD), featuring blue text and a stylized design of a person within the letter
  • Logo for Lymphoma Canada, featuring a purple circle with a stylized branching tree design and black text.
  • Logo for the Leukemia & Lymphoma Society of Canada, featuring a red droplet and grey text.
  • Logo for CLL LLC Canada, featuring a stylized red maple leaf with a drop in the center, symbolizing the Canadian focus and perhaps a healthcare or medical theme.